06.11.18
ICON plc has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system, to manage workflow and help to ensure data quality for enhanced endpoint event adjudication services.
Judi, an integrated, cloud-based SaaS tool, provides flexibility that enables the implementation of complex endpoint and adverse event processes, delivering fewer queries, higher transparency and increased quality for clients, according to the company.
ICON has already successfully deployed Judi for thousands of events across multiple therapeutic areas including oncology, obesity and diabetes. It has established relationships with more than 400 experts and key opinion leaders around the world, and works with multiple partners and Academic Research Organizations in support of Data Monitoring Committees and event adjudication.
“Judi provides a purpose-built solution for endpoint adjudication that enables efficient database set-up and data extraction, and manages workflow effectively,” said Craig McLendon, senior director, Adjudication and Data Monitoring Committees Management, ICON. “Combining ICON’s adjudication experience and expertise with innovative technology from AG Mednet enables us provide a world-class service for even the most demanding endpoint adjudication projects”.
“We developed Judi from the ground up, incorporating a level of flexibility that enables quality and accuracy in reported data from studies. ICON has been an ideal partner in ensuring that both the development and the implementation of Judi meet the technical and clinical needs of investigator sites, CRO reviewers, adjudicators and clinical event committees,” said Abraham Gutman, president and chief executive officer, AG Mednet.
Judi, an integrated, cloud-based SaaS tool, provides flexibility that enables the implementation of complex endpoint and adverse event processes, delivering fewer queries, higher transparency and increased quality for clients, according to the company.
ICON has already successfully deployed Judi for thousands of events across multiple therapeutic areas including oncology, obesity and diabetes. It has established relationships with more than 400 experts and key opinion leaders around the world, and works with multiple partners and Academic Research Organizations in support of Data Monitoring Committees and event adjudication.
“Judi provides a purpose-built solution for endpoint adjudication that enables efficient database set-up and data extraction, and manages workflow effectively,” said Craig McLendon, senior director, Adjudication and Data Monitoring Committees Management, ICON. “Combining ICON’s adjudication experience and expertise with innovative technology from AG Mednet enables us provide a world-class service for even the most demanding endpoint adjudication projects”.
“We developed Judi from the ground up, incorporating a level of flexibility that enables quality and accuracy in reported data from studies. ICON has been an ideal partner in ensuring that both the development and the implementation of Judi meet the technical and clinical needs of investigator sites, CRO reviewers, adjudicators and clinical event committees,” said Abraham Gutman, president and chief executive officer, AG Mednet.